Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Ironwood Pharmaceuticals (IRWD) Leases (2016 - 2026)

Ironwood Pharmaceuticals' Leases history spans 16 years, with the latest figure at $9.3 million for Q4 2025.

  • On a quarterly basis, Leases fell 15.31% to $9.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.3 million, a 15.31% decrease, with the full-year FY2025 number at $9.3 million, down 15.31% from a year prior.
  • Leases hit $9.3 million in Q4 2025 for Ironwood Pharmaceuticals, down from $9.8 million in the prior quarter.
  • Over the last five years, Leases for IRWD hit a ceiling of $16.3 million in Q1 2021 and a floor of $9.3 million in Q4 2025.
  • Historically, Leases has averaged $13.0 million across 5 years, with a median of $13.1 million in 2023.
  • Biggest five-year swings in Leases: decreased 6.69% in 2021 and later dropped 15.31% in 2025.
  • Tracing IRWD's Leases over 5 years: stood at $15.4 million in 2021, then fell by 8.64% to $14.0 million in 2022, then dropped by 10.25% to $12.6 million in 2023, then decreased by 12.38% to $11.0 million in 2024, then dropped by 15.31% to $9.3 million in 2025.
  • Business Quant data shows Leases for IRWD at $9.3 million in Q4 2025, $9.8 million in Q3 2025, and $10.2 million in Q2 2025.